I think [MGR] is a quality asset with an M&A tilt to it given the quality of its portfolio. Its a buy" - Jun Bei Liu

Jun Bei Liu from Tribeca Investment Partners and Claude Walker from A Rich Life go in-depth and stock specific. Stocks covered: IFM, SGM, RAC, CHN, MGR, SES, SEK, HZN, CGF, BRN. For our future fund stock series, Jun Bei picked Pro Medicus (PME).

See acast.com/privacy for privacy and opt-out information.